Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00768170 | MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) | PHASE1 | COMPLETED | 10 | — | — | Sep 1, 2008 | May 1, 2009 | Jul 3, 2015 | - | — |
| NCT00751413 | Plasma Levels of MK0633 in Children Ages 6-12 (0633-023) | PHASE1 | COMPLETED | 22 | — | — | Aug 1, 2008 | Jan 1, 2009 | Jun 1, 2015 | - | — |
| NCT00646789 | A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019) | PHASE1 | COMPLETED | 12 | — | — | May 1, 2008 | Jul 1, 2008 | Jun 1, 2015 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | MK0633 |
| Name | Type | Description |
|---|---|---|
| MK0633 | DRUG | MK0633 (50 mg) Oral, single dose |
| Comparator: MK0633 | DRUG | A single dose of MK0633 10 mg or 25 mg film coated tablet. Dose will be based on patient weight. |
Inclusion Criteria: * Patient Is Judged To Be In Good Health, Other Than Having Mild To Moderate Asthma, Based On Medical History, Physical Examination, Vital Signs, And Laboratory Safety Tests * Patient Has No Clinically Significant Abnormality On Electrocardiogram (Ecg) Performed At The Prestudy ...